Armando Orlandi

ERCC1 Induction after Oxaliplatin Exposure May Depend on KRAS Mutational Status in Colorectal Cancer Cell Line: In Vitro Veritas

A. Orlandi, A. Strippoli, M. Basso, 2015, Journal of Cancer.

Anti‐tumour and anti‐angiogenetic effects of zoledronic acid on human non‐small‐cell lung cancer cell line

A. Cassano, C. Bagalá, M. Salvatore, 2011, Cell Proliferation.

Association of IL-8 and eNOS polymorphisms with clinical outcomes in bevacizumab-treated breast cancer patients: an exploratory analysis

A. Orlandi, A. Inno, E. Capoluongo, 2015, Clinical and Translational Oncology.

AMAROS Study: Overall Survival in Breast Cancer Subtypes.

A. Orlandi, R. Masetti, G. Franceschini, 2015, Clinical oncology (Royal College of Radiologists (Great Britain)).

Trastuzumab-induced corneal ulceration: successful no-drug treatment of a “blind” side effect in a case report

A. Orlandi, A. Caporossi, A. Cassano, 2015, BMC Cancer.

A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation

T. Cenci, L. Larocca, D. Santini, 2017, British Journal of Cancer.